Physician Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bayer HealthCare, LLC
Companies announce agreements for new cystic fibrosis assay
June 15th, 2005
EraGen Biosciences, a molecular-diagnostics company, and Bayer HealthCare, LLC, diagnostics division, a member of the Bayer Group (BAY), announced that EraGen has licensed its patented MultiCode-PLx System to Bayer HealthCare in an exclusive worldwide agreement for cystic fibrosis. Bayer HealthCare will provide laboratories with what the company says is a rapid, easy-to-use cystic fibrosis assay capable of being automated for mutation carrier screening, as well as for neonatal and newborn testing. The agreement also provides Bayer HealthCare with additional rights enabling Bayer HealthCare to expand its presence in the genetics-based diagnostics...
Source: Physician Law Weekly (2005-06-15)
|
